COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 28 filers reported holding COCRYSTAL PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $42,000 | -28.8% | 143,474 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -25.3% | 143,474 | 0.0% | 0.00% | – |
| Q1 2022 | $79,000 | -15.1% | 143,474 | 0.0% | 0.00% | – |
| Q4 2021 | $93,000 | -38.4% | 143,474 | 0.0% | 0.00% | – |
| Q3 2021 | $151,000 | -15.6% | 143,474 | 0.0% | 0.00% | – |
| Q2 2021 | $179,000 | +47.9% | 143,474 | +64.7% | 0.00% | – |
| Q1 2021 | $121,000 | +10.0% | 87,130 | +7.6% | 0.00% | – |
| Q4 2020 | $110,000 | +39.2% | 80,967 | -4.5% | 0.00% | – |
| Q3 2020 | $79,000 | -30.1% | 84,792 | +13.9% | 0.00% | – |
| Q2 2020 | $113,000 | +352.0% | 74,433 | +111.0% | 0.00% | – |
| Q1 2020 | $25,000 | +257.1% | 35,273 | +139.4% | 0.00% | – |
| Q4 2019 | $7,000 | -76.7% | 14,733 | 0.0% | 0.00% | – |
| Q3 2019 | $30,000 | -14.3% | 14,733 | 0.0% | 0.00% | – |
| Q2 2019 | $35,000 | -18.6% | 14,733 | -7.3% | 0.00% | – |
| Q1 2019 | $43,000 | -12.2% | 15,899 | +17.2% | 0.00% | – |
| Q4 2018 | $49,000 | +44.1% | 13,565 | +1.2% | 0.00% | – |
| Q3 2018 | $34,000 | -46.0% | 13,399 | -22.5% | 0.00% | – |
| Q2 2018 | $63,000 | – | 17,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 5,612,037 | $3,087,000 | 0.46% |
| Parallel Advisors, LLC | 182,708 | $102,000 | 0.00% |
| Clean Yield Group | 5,000 | $3,000 | 0.00% |
| Verition Fund Management LLC | 160,000 | $88,000 | 0.00% |
| Renaissance Technologies | 1,704,328 | $937,000 | 0.00% |
| Virtu Financial LLC | 14,237 | $8,000 | 0.00% |
| Western Wealth Management, LLC | 22,815 | $13,000 | 0.00% |
| BRIGHTON JONES LLC | 28,000 | $15,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 107,695 | $59,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 965 | $0 | 0.00% |